Highly Sensitivity Alzheimer’s Blood Test Detects Dementia Years Before Symptoms Appear
Apollo Health's BrainScan test detects early signs of Alzheimer's and neurodegenerative diseases through a non-invasive blood test.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
New Alzheimer’s Blood Test Available to Consumers
Apollo Health unveiled an Alzheimer's disease test which uses three blood tests to detect Alzheimer's pathology.
Dementias & Alzheimer’s
Latest
Roche and ALZpath Partner on Alzheimer’s Blood Test
ALZpath and Roche will develop a blood test for Alzheimer's diagnosis using the pTau217 antibody on the Roche Elecsys platform.
New Blood Test Validated for Early Alzheimer’s Detection
New data supports the potential value of the SOBA-AD test as a blood-based tool for the selective detection of Alzheimer’s disease.
Read More
This Blood Test Could Provide Significant Cost Savings in Alzheimer’s Diagnosis
The test helps healthcare providers better determine the presence of amyloid plaques in the brain, a hallmark sign of Alzheimer’s disease.
Read More
How Amyloid Blood Test Could Transform Alzheimer’s Diagnostics
This blood test could help physicians establish that Alzheimer’s disease is likely not the cause of patients’ mild cognitive impairment.
Read More
Skin Biopsy is Effective at Detecting Neurodegenerative Diseases
A skin biopsy can detect an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson’s disease, at high positivity rates.
Read More
Alzheimer’s Blood Test Identifies Cognitive Impairment with High Accuracy
New research finds that the PrecivityAD2 blood test can identify brain amyloid status with values that approximate those of PET imaging.
Read More
Neurocode Launches pTau217 Blood Test for Alzheimer’s Diagnosis
Neurocode launched a blood test that can be used in the diagnosis of Alzheimer’s disease based on circulating level of pTau217 in the blood.
Read More
Promising Pathways to Simplified Alzheimer’s Diagnosis Identified
The study revealed a correlation between several blood tests with the presence of amyloid plaques in the brain, a hallmark of Alzheimer’s.
Read More
Neuroscientists Develop Highly Accurate Blood Test for Alzheimer’s and MCI
An international research collaboration developed a blood test for the early detection of Alzheimer’s disease and mild cognitive impairment.
Read More
Alzheimer’s Blood Test Performs as Well as Spinal Fluid Tests
A simple blood test to diagnose Alzheimer’s may replace more invasive and expensive screening methods such as spinal taps and brain scans.
Read More
Researchers Use AI to Predict and Detect Alzheimer’s
Researchers identified diagnostic metabolic biomarkers that can help them develop AI tools to detect Alzheimer’s disease in its early stages.
Read More
Lighting up Alzheimer’s-Related Proteins for Earlier Disease Detection
Researchers have developed a tool that could help monitor Alzheimer’s progression or distinguish between different amyloid-related conditions.
Read More
New Blood Test Shows Promise for Early Alzheimer’s Diagnosis
A new blood test has shown high accuracy in screening for Alzheimer’s disease biomarkers before the onset of symptoms.
Read More
New Scientific Advisory Board to Guide Strategy of Skin Test for Alzheimer’s Diagnosis
The new members of the SAB will expand research and market development of the company’s proprietary Alzheimer’s DISCERN skin test.
Read More
How AI is Helping Early Alzheimer’s Diagnosis Become a Reality
As AI continues to help support new diagnostic solutions, the outlook for an effective Alzheimer’s diagnosis looks brighter than ever.
Read More
Test that Predicts Dementia Progression Gets FDA Approval
BrainSee harnesses Darmiyan’s patented core proprietary technology, powered by advanced whole-brain image analysis and medical AI.
Read More